Co-Founder And President
Gross Advantage
AeroLeads people directory · profile
Iris Grossman, Phd Email & Phone Number
Co-founder and President
at
GROSS Advantage
1 work email found
@isragene.com
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
Co-founder and President
Location
Newton, Massachusetts, United States
Who is Iris Grossman, Phd? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Iris Grossman, Phd is listed as Co-founder and President at GROSS Advantage, based in Newton, Massachusetts, United States. AeroLeads shows a work email signal at isragene.com and a matched LinkedIn profile for Iris Grossman, Phd.
Iris Grossman, Phd previously worked as Chief Therapeutics Officer at Eleven Therapeutics and Chief Strategy Officer (CSO) at Eleven Therapeutics. Iris Grossman, Phd holds B.Sc. & Direct Phd, Medicine / Pharmacogenetics from Technion - Israel Institute Of Technology.
Company email context
Email format at GROSS Advantage
This section adds company-level context without repeating Iris Grossman, Phd's masked contact details.
*@isragene.com
68% confidence
AeroLeads found 1 current-domain work email signal for Iris Grossman, Phd. Compare company email patterns before reaching out.
Profile bio
About Iris Grossman, Phd
I am a strategic leader with >20 years of Big Pharma and start-up biotech experience, leveraging Personalized Medicine approaches across the continuum of discovery, development and market positioning. Deeply rooted in science and analytics, I leverage my medical sciences, human genetics and Digi-/bio-marker training, to devise corporate strategies, multi-year partnerships and effective IP-backed value propositions. Portfolios managed span a wide variety of therapeutic areas, with particular emphasis on neurological diseases, autoimmunity and metabolic diseases. I have repeatedly built and developed high performing multi-disciplinary groups of experimentalists, data scientists, clinicians and pharmacologists. Collaboratively, these teams have consistently delivered high quality therapeutic and/or diagnostic results, utilizing cutting-edge innovation within a patient-centric culture.
Listed skills include Biotechnology, Clinical Trials, Pharmaceutical Industry, Drug Development, and 33 others.
Current workplace
Iris Grossman, Phd's current company
Company context helps verify the profile and gives searchers a useful next step.
19 roles · 16 years
Iris Grossman, Phd work experience
A career timeline built from the work history available for this profile.
Chief Therapeutics Officer
CurrentChampion, supervise and manage the realization of Eleven's technology platforms into therapeutic assets (payloads and/or delivery vehicles) in the RNAi space, including R&D activities (Lead Selection & Optimization through to advanced clinical phases), IP and BD (partnerships and fundraising)
May 2022 - Present
Chief Strategy Officer (Cso)
Sep 2021 - Jul 2022
Founding Advisor, Sab Member
Apr 2020 - Aug 2021
Strategic Founder Advisor
Current
Modulight.Bio
#ModuLight.bio develops life transforming medicines against devastating neurological disorders, such as drug-resistant focal Epilepsy, Parkinson’s disease, and severe neuropathic pain syndromes, by harnessing next-generation optogenetic solutions.
Jul 2022 - Present
Co-Founder And President
Current
Gross Advantage (Formerly Isragene)
GROSS Advantage (formerly IsraGene) is a therapeutic strategy consultancy, serving the continuum of drug and diagnostic R&D, leveraging principles of human genetics, pharmacogenomics, biomarkers and digital-markers. GROSS Advantage is dedicated to the successful discovery and development of drugs worldwide, with a specific focus on the smooth and effective.
Nov 2007 - Present
Chairwoman, Sab
Jan 2023 - Dec 2024
Sab Member
BC Platforms is a world leader in providing powerful genomic data management and analysis solutions to address some of the biggest healthcare challenges today by leveraging the convergence of genomics and healthcare information technologies. Our high performing genomic data management platform enables flexible data integration, secure analysis and.
Oct 2018 - Dec 2024
Chief Scientific Officer (Acting)
Amide is at the forefront of a new biotech industry—fully synthetic proteins—thatboasts the combinatorial flexibility of small molecules, alongside the physiologicaladvantages of biologics. As the experts in this new field, we champion the proteintherapeutic 2.0 market.Amide was founded on the seminal inventions of Prof. Brad Pentelute enabling.
Oct 2020 - Sep 2021
Chief Scientific Officer
As CSO I served as the scientific face of the company, effectively leading, creating, and communicating R&D strategies across the scope of discovery and development activities and collaborations.CAMP4 Solves the riddle of gene regulation in order to develop effective and safe therapeutics. We discover and harness the mechanisms by which human cells respond.
Apr 2018 - Jun 2020
Vp, Head Of Early Stage Clinical Development, Global R&D
Tuning drug discovery and development to the voices of patients, physicians and disease/therapy, ESD incorporates key functions that innovatively and creatively coordinates the right inputs as early as possible along the R&D pipeline: clinical pharmacology and pharmacometrics, personalized and predictive medicine, analytics and big data, translational.
Aug 2017 - Mar 2018
Vice President, Head Of Personalized & Predictive Medicine, Analytics And Big Data
Employing cutting-edge biomarker research and Big Data analytics to innovatively inform and drive decision making that improves the benefit-risk profile of specialty, generic and technology offerings for patients, healthcare providers and payers. The unit generates strategic, evidence-based insight that informs Teva's entire pipeline, from discovery.
Sep 2015 - Jul 2017
Vice President, Global Head Of Personal Medicine And Pharmacogenomics
The PMP unit is in charge of integrating biomarker research and treatment personalization into Teva's pipeline where a clear value-added proposition can offer patients and healthcare providers a clinically meaningful benefit/risk profile improvement. We support specialty and generic/repositioning pipelines through rigorous science and robust.
Nov 2014 - Aug 2015
Sr. Director, Global Head Of Personalized Medicine And Pharmacogenomics
May 2013 - Oct 2014
Member, Board Of Advisors
Zinfandel Pharmaceuticals
2010 - May 2013
Director, Pharmacogenetics Consultancy
Cabernet Pharmaceuticals
Cabernet Pharmaceuticals is a pharmacogenetics and project-management consultancy committed to helping its clients develop drugs with a greater chance of success.Our consultants bring deep experience in pharmacogenetics (PGx) to improving R&D pipeline management, securing regulatory approval, and enhancing market acceptance. The consultancy relationship.
Dec 2008 - Sep 2011
Pharmacogenetics Manager
Pharmacogenetics lead for the Infectious Diseases therapeutic area, as well as program support for neurosciences and bio-pharmaceutics
Apr 2007 - Dec 2008
Pharmacogenetics Consultant
Mar 2005 - Mar 2007
Research Associate - Population Genetics And Pharmacogenetics
Mar 2005 - Mar 2007
5 education records
Iris Grossman, Phd education
B.Sc. & Direct Phd, Medicine / Pharmacogenetics
Technion - Israel Institute Of Technology
Boardroom Ready, Executive Women In Bio (Ewib), Business
The George Washington University
Executive Healthtech Program
Harvard Business School
Postgraduate Degree, Genome Sciences/Genomics
Duke University School Of Medicine
Phd (On-Site Joint Mentorship, Degree From The Technion), Pharmacogenetics And Population Genetics
Weizmann Institute Of Science
FAQ
Frequently asked questions about Iris Grossman, Phd
Quick answers generated from the profile data available on this page.
What company does Iris Grossman, Phd work for?
Iris Grossman, Phd works for GROSS Advantage.
What is Iris Grossman, Phd's role at GROSS Advantage?
Iris Grossman, Phd is listed as Co-founder and President at GROSS Advantage.
What is Iris Grossman, Phd's email address?
AeroLeads has found 1 work email signal at @isragene.com for Iris Grossman, Phd at GROSS Advantage.
Where is Iris Grossman, Phd based?
Iris Grossman, Phd is based in Newton, Massachusetts, United States while working with GROSS Advantage.
What companies has Iris Grossman, Phd worked for?
Iris Grossman, Phd has worked for Gross Advantage, Eleven Therapeutics, Modulight.Bio, Gross Advantage (Formerly Isragene), and Bc Platforms.
How can I contact Iris Grossman, Phd?
You can use AeroLeads to view verified contact signals for Iris Grossman, Phd at GROSS Advantage, including work email, phone, and LinkedIn data when available.
What schools did Iris Grossman, Phd attend?
Iris Grossman, Phd holds B.Sc. & Direct Phd, Medicine / Pharmacogenetics from Technion - Israel Institute Of Technology.
What skills is Iris Grossman, Phd known for?
Iris Grossman, Phd is listed with skills including Biotechnology, Clinical Trials, Pharmaceutical Industry, Drug Development, Life Sciences, Bioinformatics, Genomics, and Neuroscience.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial